US-Listed Biological Products, (No Diagnostic Substances) — Net Income Percentiles, FY 2019
Population: 164 US-listed companies (SIC 2836), fiscal year 2019; fiscal year ends 2019-06-30 to 2020-05-31.
Cite as: FACTANKER, https://factanker.com/industries/sic-2836/net-income/2019
Fiscal year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · latest
| 10th percentile | $-133.7M |
|---|---|
| 25th percentile | $-75.3M |
| Median | $-37.0M |
| 75th percentile | $-11.5M |
| 90th percentile | $-132.7k |
| Mean | $61.8M |
| Minimum | $-789.6M |
| Maximum | $7.8B |
Methodology & sources
Net Income as filed, one fiscal year per company; percentiles computed in the database via percentile_cont, never by a model. Fiscal year 2019 = fiscal years ending 2019-06-01 to 2020-05-31 (majority-overlap rule; June-ending fiscal years count toward the ending calendar year).
Source: SEC EDGAR filings (public domain). Data: FACTANKER registry, precomputed 2026-09-07.
Net Income as filed, one fiscal year per company; percentiles computed in the database via percentile_cont, never by a model. Fiscal year 2019 = fiscal years ending 2019-06-01 to 2020-05-31 (majority-overlap rule; June-ending fiscal years count toward the ending calendar year).
Source: SEC EDGAR filings (public domain). Data: FACTANKER registry, precomputed 2026-09-07.
Evidence samples
Latest Net Income percentiles (live) · All Biological Products, (No Diagnostic Substances) benchmarks · All industries